IRIS
FARINA, ANTONIETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.275
EU - Europa 2.425
AS - Asia 2.270
SA - Sud America 313
Continente sconosciuto - Info sul continente non disponibili 155
AF - Africa 34
OC - Oceania 8
Totale 9.480
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.196
SG - Singapore 960
CN - Cina 547
RU - Federazione Russa 527
IE - Irlanda 499
IT - Italia 283
DE - Germania 259
BR - Brasile 256
TR - Turchia 220
HK - Hong Kong 205
SE - Svezia 203
VN - Vietnam 200
GB - Regno Unito 153
UA - Ucraina 132
FI - Finlandia 111
FR - Francia 104
CA - Canada 44
IN - India 34
CZ - Repubblica Ceca 31
PL - Polonia 21
AR - Argentina 20
BE - Belgio 20
BD - Bangladesh 18
JP - Giappone 18
ES - Italia 17
AT - Austria 16
MX - Messico 16
NL - Olanda 16
ZA - Sudafrica 16
KR - Corea 11
LT - Lituania 10
EC - Ecuador 9
IQ - Iraq 9
UZ - Uzbekistan 8
EU - Europa 7
UY - Uruguay 7
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CL - Cile 5
EG - Egitto 5
ID - Indonesia 5
CO - Colombia 4
DZ - Algeria 4
MA - Marocco 4
VE - Venezuela 4
BY - Bielorussia 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
SA - Arabia Saudita 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
ET - Etiopia 1
GN - Guinea 1
GR - Grecia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TC - Turks e Caicos 1
TH - Thailandia 1
Totale 9.332
Salva come PNG Salva come JPEG
Città #
Singapore 581
Jacksonville 511
Chandler 504
Dublin 498
San Jose 448
Dallas 350
Ashburn 263
Hong Kong 200
Santa Clara 187
Boardman 174
Council Bluffs 135
New York 120
Izmir 101
The Dalles 97
Nanjing 96
Beijing 93
Wilmington 83
San Mateo 79
Moscow 77
Lawrence 67
Princeton 67
Ho Chi Minh City 65
Munich 64
Lauterbourg 53
Ann Arbor 52
Los Angeles 50
Milan 44
Dearborn 42
L'aquila 41
Nanchang 37
Hanoi 33
Shenyang 31
Turku 29
Brno 28
Verona 27
São Paulo 25
Hefei 24
Teramo 24
Frankfurt am Main 23
Helsinki 23
Woodbridge 23
Hebei 22
Rome 21
Seattle 21
Tianjin 21
Brussels 20
Dong Ket 20
Falls Church 20
Warsaw 19
Tokyo 18
Des Moines 17
Shanghai 17
Montreal 16
Orem 16
Jinan 15
Toronto 15
Brooklyn 14
Chennai 14
Columbus 14
L’Aquila 14
Mountain View 14
Nuremberg 14
Boston 13
Bremen 13
Denver 13
Jiaxing 12
Johannesburg 12
Stockholm 12
Guangzhou 11
Kunming 10
Norwalk 10
Phoenix 10
Auburn Hills 9
Changsha 9
Philadelphia 9
Falkenstein 8
London 8
Rio de Janeiro 8
Amsterdam 7
Ankara 7
Assisi 7
Atlanta 7
Hangzhou 7
Houston 7
Hải Dương 7
Ningbo 7
Poplar 7
Salvador 7
Buffalo 6
Campinas 6
Curitiba 6
Da Nang 6
Impruneta 6
Kitzingen 6
Manchester 6
Montevideo 6
San Francisco 6
Taizhou 6
Tashkent 6
Washington 6
Totale 6.140
Salva come PNG Salva come JPEG
Nome #
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TRKIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma 185
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin 175
NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis 175
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 164
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation 160
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 156
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 155
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases 153
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. 153
The enemy from within: Miss-localization of a compromised receptor as a mechanism for TrkAIII oncogenic activity 147
Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es) 145
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 144
A TaqMan-Based qRT-PCR Assay for Accurate Evaluation of the Oncogenic TrkAIII Splice Variant in Tumor cDNAs 141
The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells 140
All-trans-retinoic acid induces nuclear factor kappa B activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma cells 139
Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappa B elements 138
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target 138
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 137
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. 135
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells 135
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain. 135
Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion 134
A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced WT BRAF Melanoma Patients 132
Neurotrophin and Neurotrophin Receptor Involvement in Human Neuroblastoma 131
A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer 131
Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule 1 (ICAM-1) gene are required for induction of transcription by IFN-gamma 130
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells 128
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 127
T-cell restricted and unrestricted expression of transfected human interleukin-2 gene: phorbol ester- and calcium-inducible versus constitutive expression. 125
Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in Neuroblastoma 124
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity 122
TRASFORMING GROWTH FACTOR-BETA 1 ENHANCES THE INVASIVITY OF HUMAN MDBA-MB-231 BREAST CANCER CELLS BY UP REGULATING UROKINASE ACTIVITY 122
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 120
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: A pilot study 120
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 120
FOLLICLE-STIMULATING HORMONE INCREASES THE EXPRESSION OF TISSUE INHIBITORS OF METALLOPROTEINASES TIMP-1 AND TIMP-2 AND INDUCES TIMP-1 AP-1 SITE BINDING COMPLEX(ES) IN PREPUBERTAL RAT SERTOLI CELLS 117
Alternative TrkA splicing and neuroblastoma 115
TrkAIII expression in the thymus 115
fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. 115
Cis Golgi network-associated TrkAIII targets the interphase centrosome and promotes genetic instability 114
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. 114
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma 114
Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens. 112
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. 112
RETINOIC ACID-ENHANCED INVASION THROUGH RECONSTITUTED BASEMENT MEMBRANE BY HUMAN SK-N-SH NEUROBLASTOMA CELLS INVOLVES MEMBRANE-ASSACIATED TISSUE-TYPE PLASMINOGEN ACTIVATOR 110
TrkAIII: A Novel Hypoxia-regulated Alternative TrkA Splice Variant of Potential Physiological and Pathological Importance 110
TRKAIII COMMUNICATES ER-STRESS TO THE MITO-CHONDRIA IN NEUROBLASTOMA CELLS, RESULTING INGLYCOLYTIC METABOLIC ADAPTATION 110
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 110
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site 109
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. 108
Thioredoxin inhibits microvascular endothelial capillary tubule formation 107
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells 106
Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate 106
Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival 106
POSITIVE AND NEGATIVE REGULATION OF THE COMPOSITE OCTAMER MOTIF OF THE INTERLEUKIN 2 ENHANCER BY AP-1, OCT-2, AND RETINOIC ACID RECEPTOR 105
Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences. 105
CELL-SPECIFIC BIFUNCTIONAL ROLE OF JUN ONCOGENE FAMILY MEMBERS ON GLUCOCORTICOID RECEPTOR-DEPENDENT TRANSCRIPTION 105
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 104
Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. 104
Alternative TrkA splicing and Cancer 104
The alternative TRKAIII splice variant targets the centrosome and promotes genetic instability 103
Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. 99
TRANSCRIPTIONAL MODULATION OF THE HUMAN INTERCELLULAR ADHESION MOLECULE GENE I (ICAM-1) BY RETINOIC ACID IN MELANOMA CELLS 98
Alternative TrkAIII splicing and Cancer 98
AN EARLY RESPONSE OF AN AP1-JUND COMPLEX DURING T-CELL ACTIVATION 96
AUTOIMMUNE ANTIGEN KU IS ENRICHED ON OLIGONUCLEOTIDE COLUMNS DISTINCT FROM THOSE CONTAINING THE OCTAMER BINDING PROTEINDNA CONSENSUS SEQUENCE 96
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced Death of SH-SY5Y Neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, whitin the context of a tumour stem cell-like phenotype 96
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 93
Hypoxia-induced alternative TrkA splicing and reoxygenation-dependent TrkAIII activation: A cycling hypoxia-regulated resistance mechanism in neuroblastoma. 93
A TAQMAN-BASED QRT-PCR ASSAY FOR DETECTING TRKAIII EXPRESSION IN TUMOR TISSUE RNAS 92
Studies on potentially druggable pathways that regulate stress-induced TrkAIII mitochondrial internalization, cleavage and activation in human neuroblastoma cells 92
GLUCORTICOID RECEPTOR-MEDIATED SUPPRESSION OF THE INTERLEUKIN 2 GENE EXPRESSION THROUGH IMPAIRMENT OF THE COOPERATIVITY BETWEEN NUCLEAR FACTOR OF ACTIVATED T CELLS AND AP-1 ENHANCER ELEMENTS 90
The Alternative TrkAIII splice variant by neuroblastomas and glioblastomas targets the centrosome and promotes genetic instability 90
Multiple components are required for sequence recognition of the AP1 site in the gibbon ape leukemia virus enhancer. 88
Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer. 84
THE KU COMPLEX IS MODULATED IN RESPONSE TO VIRAL INFECTION AND OTHER CELLULAR CHANGES 83
NGF sensitizes TrKA expressing SH-SY5Y nuroblastoma cells to TRAIL-induced apoptosisi 77
PROSTAGLANDIN E2 INHIBITS THE INTERLEUKIN-2 PROMOTER ACTIVITY THROUGH DOWN-REGULATION OF THE OCT-DEPENDENT TRANSCRIPTION OF THE OCTAMER MOTIF 74
TRKAIII PROMOTES PD-L1 EXPRESSION IN SH-SY5Y NEUROBLASTOMA CELLS 71
NGF Sensitizes TrkA SH-SY5Y Neuroblastoma Cells to TRAIL-Induced Apoptosis 51
Jurkat T-Cell Antigen-Independent Elimination of PMA-Activated Neuroblastoma Cells Is Triggered by CCL2/CCR2, Depends Upon Lipid Raft LFA1/ICAM1 Immune Synapses, Is Mediated by m-TRAIL and Is Augmented by the TrkAIII Oncoprotein 40
Alternative Splicing of the NF-Y Subunit, NF-YA, in Neuroblastoma Phenotype Heterogeneity 12
Alternative Splicing in Human Viral Oncogenesis and Tumor Progression 6
null 5
Totale 9.480
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.696
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022418 0 36 73 27 26 13 12 26 23 11 35 136
2022/20231.419 94 97 35 148 128 148 3 70 629 5 31 31
2023/2024373 47 16 37 41 25 103 1 5 5 12 7 74
2024/20251.643 39 25 134 86 197 134 282 116 291 99 123 117
2025/20263.296 140 303 260 453 347 226 511 100 288 435 173 60
2026/2027183 99 84 0 0 0 0 0 0 0 0 0 0
Totale 9.480